This project is designed to develop new and selective [I-123] labeled 5-HT1A receptor agonists and antagonists as single photon emission computed tomography (SPECT) imaging agents for evaluation of this serotonin (5-HT) receptor subtype in brain. The serotonin neurotransmission system is an important CNS network regulating various normal neurological functions and psychological behavior including anxiety and affective states. The serotonin receptor subtype 5-HT1A plays an important function as somatodendritic autoreceptor (presynaptic) in the dorsal raphe nucleus and as a postsynaptic receptor in 5-HT terminal fields. Development of SPECT imaging agents will facilitate the study of the basic pharmacology of 5-HT1A receptors. Moreover their interactions with various agents may improve our understanding of normal CNS function as well as in disease states. In this project, the design of 5-HT1A ligands will be based on the agonist, (R)-(+)-8-OH-PIPAT (Kd=0.09nM), and the antagonist, p-MPPI (Kd=0.3nM), which were both developed by the applicant. Because of the failure of these two agents to show desired localization in human SPECT studies despite promising in vitro characteristics, new ligands with high affinity and extended in vivo stability will be prepared and evaluated. Ultimately, the best imaging agent for quantitative SPECT will be selected from these new ligands.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS035120-02
Application #
2379769
Study Section
Diagnostic Radiology Study Section (RNM)
Program Officer
Jacobs, Tom P
Project Start
1996-05-01
Project End
2000-02-29
Budget Start
1997-03-01
Budget End
1998-02-28
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Kung, Mei-Ping; Choi, Seok-Rye; Hou, Catherine et al. (2004) Selective binding of 2-[125I]iodo-nisoxetine to norepinephrine transporters in the brain. Nucl Med Biol 31:533-41
Acton, P D; Choi, S R; Hou, C et al. (2001) Quantification of serotonin transporters in nonhuman primates using [(123)I]ADAM and SPECT. J Nucl Med 42:1556-62
Choi, S R; Hou, C; Oya, S et al. (2000) Selective in vitro and in vivo binding of [(125)I]ADAM to serotonin transporters in rat brain. Synapse 38:403-12
Oya, S; Choi, S R; Hou, C et al. (2000) 2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligand. Nucl Med Biol 27:249-54
Zhuang, Z; Choi, S; Hou, C et al. (2000) A novel serotonin transporter ligand: (5-iodo-2-(2-dimethylaminomethylphenoxy)-benzyl alcohol. Nucl Med Biol 27:169-75
Acton, P D; Mu, M; Plossl, K et al. (1999) Single-photon emission tomography imaging of serotonin transporters in the nonhuman primate brain with [(123)I]ODAM. Eur J Nucl Med 26:1359-62
Kung, M P; Hou, C; Oya, S et al. (1999) Characterization of [(123)I]IDAM as a novel single-photon emission tomography tracer for serotonin transporters. Eur J Nucl Med 26:844-53
Oya, S; Kung, M P; Acton, P D et al. (1999) A new single-photon emission computed tomography imaging agent for serotonin transporters: [123I]IDAM, 5-iodo-2-((2-((dimethylamino)methyl)phenyl)thio)benzyl alcohol. J Med Chem 42:333-5
Acton, P D; Kung, M P; Mu, M et al. (1999) Single-photon emission tomography imaging of serotonin transporters in the non-human primate brain with the selective radioligand [(123)I]IDAM. Eur J Nucl Med 26:854-61
Zhuang, Z P; Kung, M P; Mu, M et al. (1998) Isoindol-1-one analogues of 4-(2'-methoxyphenyl)-1-[2'-[N-(2""-pyridyl)-p-iodobenzamido]ethyl]pipera zine (p-MPPI) as 5-HT1A receptor ligands. J Med Chem 41:157-66